Buyers should treat design freeze as the release of a controlled baseline, not as a ban on improvement. Any mold design change after that point should start with a written request, move through an injection mold design review that measures part, tool, process, inventory, cost, and schedule impact, and end only after the buyer accepts the revised evidence. The supplier should not cut steel, alter a hot runner setting, or release revised parts from an informal email. This discipline protects interchangeability, traceability, and injection mold ownership across cross-border programs.
Do not let a drawing comment become a shop-floor instruction. A released injection mold engineering change should identify the affected revision, approved scope, validation evidence, effective lot, and authority to modify the tool.
01
Set the Frozen Baseline Before You Discuss a Change
A design freeze should create one agreed technical record that both buyer and supplier can identify without interpretation. Link the part number and revision to the released 3D model, drawing, material specification, cosmetic criteria, DFM decisions, tool revision, process assumptions, and accepted trial record. State which files are controlled, their issue dates, and the system or folder that is the single source of truth. NIST defines a baseline as specifications formally reviewed and agreed at a point in time that can be changed only through change-control procedures; that is a useful operating principle for a tooling program, even when the product is not regulated (Reference 2).
The buyer should also distinguish a part-design change from a tool-only correction. A revised wall, snap, datum, texture, resin, or interface can affect fit, function, regulatory obligations, packaging, and downstream assembly. A tool-only change, such as a repair to restore the released geometry, may have a narrower impact, but still requires evidence that it restored rather than changed the baseline. Do not label a change minor simply because the cut in steel looks small. The effect on the delivered part and its interfaces is what matters.
For programs spanning Europe, the United States, and the Middle East, agree the controlling language, units, approval channel, escalation route, and signatories before a problem occurs. Physical mold ownership does not automatically authorize modification. The tooling agreement should identify who may request, approve, pay for, and receive the technical data from an injection mold modification.
02
Run Every Request Through an Injection Mold Engineering Change Workflow
Separate the request from the solution. A buyer or supplier can raise a change request that describes the observed issue, affected lot or trial, requirement, evidence, urgency, and desired outcome. Engineering then proposes one or more solutions in a change order. This prevents premature approval of a machining method that does not solve the actual problem. NIST’s engineering-change research likewise distinguishes a change request from a change order and calls for impact analysis, including possible cascading effects across production (Reference 1).
Assign a unique identifier to the request and preserve its status from submission through closure. A practical route is technical review, commercial confirmation, buyer authorization, controlled execution, evidence review, and release. The people who can commit the buyer, toolmaker, molder, and quality function should be explicit. A supplier may provide feasibility advice, but feasibility is not approval to alter buyer-owned tooling.
Use a defined urgent-change route only for genuine containment, safety, or inability-to-produce events. That route can authorize temporary segregation, inspection, or a controlled trial while the decision is being made. It should not erase the need to document the final scope, evidence, and effective revision. NASA describes change management as proposal, justification, evaluation, incorporation of approved changes, and verification of implementation; its approach also differentiates changes by their impact rather than by a casual label (Reference 2).
| Change route | Typical situation | Decision package before machining | Release condition |
|---|---|---|---|
| Documentation correction | A clerical file error with no effect on released geometry or process | Affected documents, comparison, and confirmation of no physical impact | Controlled documents supersede prior copies |
| Restorative tool repair | Wear or damage must be returned to released geometry | Before-and-after condition, repair method, critical-dimension check, and owner authorization | Evidence shows restoration to the existing baseline |
| Injection mold modification | A part, gate, cooling, ejection, cavity, texture, or process capability change is proposed | Impact review, revised CAD or drawing, cost and schedule confirmation, trial and inspection plan | Buyer accepts the revised baseline and evidence |
| Urgent containment | A verified issue needs immediate control while engineering evaluates options | Issue record, lot disposition, temporary controls, and decision authority | Permanent change follows the normal controlled route |
03
Make the Injection Mold Design Review an Impact Decision
An injection mold design review after freeze should answer more than “Can this be machined?” Review the changed geometry against the part drawing, datum scheme, mating components, material shrinkage assumptions, gate and flow path, venting, cooling, ejection, side actions, shutoffs, surface finish, cavity balance, and expected inspection method. For a multi-cavity tool, determine whether every cavity is affected and how consistency will be shown. For steel-safe rework, request the remaining adjustment range and the consequence if the next trial misses the requirement.
Require a written impact statement that identifies affected documents, existing samples, work-in-process, finished inventory, purchased components, packaging, fixtures, inspection programs, and service parts. It should state whether old and new parts can mix and how labels and lot records will distinguish them. A change that preserves nominal dimensions can still change gloss, gate vestige, warpage behavior, assembly force, or cycle stability, so the review should be part-specific rather than a generic signature exercise.
Set the evidence plan before approval. Examples include CAD comparison, tool-design markup, trial conditions, CTQ dimensions, assembly checks, visual approval, material confirmation, and any required capability study. The method, sample basis, acceptance criteria, and approver must be confirmed for the project; no universal sample quantity or trial count is reliable for every tool. FDA design-control guidance, while specifically applicable to medical-device design controls, provides a useful general discipline: changes are identified, documented, reviewed, approved, and verified or validated as appropriate before implementation (Reference 3).
04
Control Execution, Trials, and Revision Traceability
After approval, issue one execution package to the responsible toolroom and withdraw superseded files from active use. The package should identify the mold asset, cavities or inserts, revision, machining boundaries, approved deviations, inspection points, and hold points. If a supplier needs clarification, pause at the hold point rather than infer intent from an old model or chat message.
Treat the first revised trial as evidence, not automatic production release. Compare results with the pre-change baseline and approved plan. Record the press and relevant process conditions if they affect interpretation, identify cavities, retain the applicable inspection report, and document any nonconformance or further adjustment. Where old and new revision parts could coexist, quarantine or clearly segregate them until the buyer issues an effective-date or effective-lot decision. This protects customers from unintended mixed revisions during export or local distribution.
Close the injection mold engineering change only when the final records agree: revised part and tool documentation, approval record, machining or repair record, trial evidence, inspection results, disposition of stock, and mold status. NASA notes that effective configuration status accounting retains current and historical documentation, change status, discrepancies, and audit actions; the same traceability helps buyers resolve later quality, warranty, and transfer questions (Reference 2).
05
Use Ownership Rights to Preserve Control, Not to Skip Governance
Injection mold ownership should be traceable to a tool identification, asset list, contractual terms, and technical-data rights. A buyer should know whether the mold base, cores, cavities, inserts, hot-runner hardware, spares, CAD, drawings, programs, inspection records, and maintenance history are covered. If a third party will mold parts, the agreement should define who may access the tool, receive the native and neutral files, authorize repairs, and approve a transfer.
However, ownership should not be used as a shortcut around technical evaluation. An owner-directed modification can still damage a shutoff, reduce steel margin, affect cooling, or create a mixed-revision problem. Ask the supplier to show the technical risk and alternatives, then record the owner’s final direction. Conversely, a supplier should not substitute materials, relocate a gate, polish a texture, or change a process window merely because it appears beneficial without the agreed authorization route.
When requesting a quote for a mold design change, send the released baseline, the issue evidence, desired outcome, affected-market requirements, and your approval roles. Ask for a separated proposal covering technical scope, assumptions, affected tooling components, evidence plan, revision deliverables, and project-confirmed cost and timing. InjeForm can review this package as the basis for a controlled tooling-change inquiry.
Practical takeaway
Before you move
to the next review.
- Freeze and label the released part, tool, drawing, CAD, material, cosmetic, and acceptance revisions before accepting change requests.
- Open a uniquely identified change request that describes the problem, evidence, urgency, affected lots, and desired outcome without prematurely dictating the solution.
- Require an injection mold design review that covers part function, interfaces, tool mechanics, cavities, material behavior, process effect, inspection, stock, and mixed-revision risk.
- Obtain written technical, commercial, and ownership-authorized approval before any non-emergency machining or parameter change intended to alter the released result.
- Agree the trial, measurement, functional, cosmetic, and document evidence needed for this project before the tool is modified.
- Mark the effective revision and segregate old from revised samples, work-in-process, and finished goods until disposition is documented.
- Close the change only after revised technical files, mold status, inspection evidence, stock disposition, and buyer acceptance are linked to the change identifier.
FAQ
Common questions
Can a supplier make a small injection mold modification without buyer approval?
Not if it changes the released tool, part, process capability, or documented acceptance basis. The agreement may permit narrowly defined restorative maintenance, but the supplier should document why the work returns the mold to the existing baseline and provide the agreed evidence. A small cut can create a large interface or cosmetic impact.
What is the difference between an engineering change request and an engineering change order?
A request states the issue, need, and evidence. An order defines the selected technical solution, affected revisions, cost and schedule implications, validation plan, and implementation authorization. Keeping them separate lets the team evaluate alternatives before committing to an injection mold modification.
Does injection mold ownership mean the buyer owns the CAD and revision history?
Not necessarily. Physical-tool ownership, native CAD access, drawings, CNC programs, maintenance records, and transfer rights should each be written into the tooling agreement. Buyers should request a clear asset and data list, plus the released revision package, rather than assuming that one ownership statement covers every item.
References
Source material
- [1] National Institute of Standards and Technology, Engineering Change Management Concepts for Systems Modeling
- [2] NASA Systems Engineering Handbook, Configuration Management
- [3] U.S. Food and Drug Administration, Design Controls
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.